Christopher (Chris) Snyder
Joel Z. and Susan Hyatt Professor in the Economics Department at Dartmouth College
Department of Economics 301 Rockefeller Hall Dartmouth College Hanover, NH 03755
Christopher Snyder is the Joel Z. and Susan Hyatt Professor in the Economics Department at Dartmouth College. He specializes in the economics of markets, contracting, and health. He is a Research Associate in the National Bureau of Economic ResearchOpens in a new window, Faculty Co-director of the Market Shaping Accelerator, and Treasurer of the Industrial Organization Society. He received his Ph.D. in Economics from the Massachusetts Institute of Technology in 1994. He lives in Hanover, New Hampshire, with his wife, Maura Doyle, who is a senior lecturer in the Economics Department.
Topics
Appearances (1)
2026-08-20
Chris Snyder Discusses FDA Drug Repurposing and Market IncentivesIn the latest episode of the Health Policy Podcast, Christopher Snyder, a professor at Dartmouth College, discusses the FDA's exploration of drug repurposing and the economic incentives surrounding it. Snyder explains how generic drugs often miss opportunities for secondary uses due to a lack of financial motivation for manufacturers after patent expiration. He also highlights the work of the Market Shaping Accelerator, a collaborative initiative aimed at enhancing innovation in public health and addressing market failures.
Notable quotes
“The idea is that often a drug that was initially discovered for one use or another actually has a second life as a different use.”
“There's a study that suggests that there might be hundreds as many as eight hundred missing treatments of generics.”
“The thing is that that incentive doesn't hold for generic drugs.”
“Once a drug goes off patent, it turns out you can actually get a patent on second uses, but you can't monetize it.”
“The costs of the clinical trials are going to be lower for a generic because it's already been proven safe for the other use.”
“Our goal is like, how can we solve big social problems that seem intractable?”
